http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 10 Feb 2025 08:05:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html <p align="justify">TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=9E3kRbcrLYY66jPZlSVWnuWU9x3qObgRlvs0WIIUqSGTNCbmsX5_pJHRrtaUEYLcb5rjqrUOzhmmueNobcpBtA==" rel="nofollow" target="_blank">www.avidbio.com</a>, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.</p> <p align="justify">The reimagined Avid website captures the company’s elevated http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html Mon, 10 Feb 2025 08:05:00 -0500 CDMO CDMOP O.00639255 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html <p align="justify">TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=9E3kRbcrLYY66jPZlSVWnuWU9x3qObgRlvs0WIIUqSGTNCbmsX5_pJHRrtaUEYLcb5rjqrUOzhmmueNobcpBtA==" rel="nofollow" target="_blank">www.avidbio.com</a>, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.</p> <p align="justify">The reimagined Avid website captures the company’s elevated http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html Mon, 10 Feb 2025 08:05:00 -0500 CDMO CDMOP O.00639255 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html <p align="justify">TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=9E3kRbcrLYY66jPZlSVWnuWU9x3qObgRlvs0WIIUqSGTNCbmsX5_pJHRrtaUEYLcb5rjqrUOzhmmueNobcpBtA==" rel="nofollow" target="_blank">www.avidbio.com</a>, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.</p> <p align="justify">The reimagined Avid website captures the company’s elevated http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html Mon, 10 Feb 2025 08:05:00 -0500 CDMO CDMOP O.00639255 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html <p align="justify">TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=9E3kRbcrLYY66jPZlSVWnuWU9x3qObgRlvs0WIIUqSGTNCbmsX5_pJHRrtaUEYLcb5rjqrUOzhmmueNobcpBtA==" rel="nofollow" target="_blank">www.avidbio.com</a>, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.</p> <p align="justify">The reimagined Avid website captures the company’s elevated http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html Mon, 10 Feb 2025 08:05:00 -0500 CDMO CDMOP O.00639255 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html <p align="justify">TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=9E3kRbcrLYY66jPZlSVWnuWU9x3qObgRlvs0WIIUqSGTNCbmsX5_pJHRrtaUEYLcb5rjqrUOzhmmueNobcpBtA==" rel="nofollow" target="_blank">www.avidbio.com</a>, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.</p> <p align="justify">The reimagined Avid website captures the company’s elevated http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html Mon, 10 Feb 2025 08:05:00 -0500 CDMO CDMOP O.00639255 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html <p align="justify">TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=9E3kRbcrLYY66jPZlSVWnuWU9x3qObgRlvs0WIIUqSGTNCbmsX5_pJHRrtaUEYLcb5rjqrUOzhmmueNobcpBtA==" rel="nofollow" target="_blank">www.avidbio.com</a>, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.</p> <p align="justify">The reimagined Avid website captures the company’s elevated http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices+Launches+New+Company+Website+Designed+to+Boost+Company+Brand+Awareness+and+Enhance+the+Visitor+Experience/24319339.html Mon, 10 Feb 2025 08:05:00 -0500 CDMO CDMOP O.00639255 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Press+Releases/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html <p align="left">TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with http://www.streetinsider.com/Globe+Newswire/Avid+Bioservices%2C+Inc.+Provides+Notice+of+Fundamental+Change+and+Make-Whole+Fundamental+Change+to+Holders+of+its+Convertible+Notes+in+Connection+with+Completed+Merger/24300069.html Wed, 05 Feb 2025 10:45:00 -0500 A.18008152 A.23164265 CDMO CDMOP O.00639255 O.01114765 O.22206752 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html <p align="justify">TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended October 31, 2024.</p> <p align="justify"><strong>Highlights from the Quarter Ended October 31, 2024:</strong></p> <p align="justify">“We delivered solid results in a competitive environment, with increased revenues and backlog offset by increased costs,” stated Nick Green, president and CEO of Avid Bioservices. “We are pleased to reach http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html Tue, 10 Dec 2024 16:05:00 -0500 A.33758567 CDMO CDMOP O.00639255 O.16915665 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html <p align="justify">TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended October 31, 2024.</p> <p align="justify"><strong>Highlights from the Quarter Ended October 31, 2024:</strong></p> <p align="justify">“We delivered solid results in a competitive environment, with increased revenues and backlog offset by increased costs,” stated Nick Green, president and CEO of Avid Bioservices. “We are pleased to reach http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html Tue, 10 Dec 2024 16:05:00 -0500 A.33758567 CDMO CDMOP O.00639255 O.16915665 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html <p align="justify">TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended October 31, 2024.</p> <p align="justify"><strong>Highlights from the Quarter Ended October 31, 2024:</strong></p> <p align="justify">“We delivered solid results in a competitive environment, with increased revenues and backlog offset by increased costs,” stated Nick Green, president and CEO of Avid Bioservices. “We are pleased to reach http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html Tue, 10 Dec 2024 16:05:00 -0500 A.33758567 CDMO CDMOP O.00639255 O.16915665 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html <p align="justify">TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended October 31, 2024.</p> <p align="justify"><strong>Highlights from the Quarter Ended October 31, 2024:</strong></p> <p align="justify">“We delivered solid results in a competitive environment, with increased revenues and backlog offset by increased costs,” stated Nick Green, president and CEO of Avid Bioservices. “We are pleased to reach http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html Tue, 10 Dec 2024 16:05:00 -0500 A.33758567 CDMO CDMOP O.00639255 O.16915665 http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html <p align="justify">TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended October 31, 2024.</p> <p align="justify"><strong>Highlights from the Quarter Ended October 31, 2024:</strong></p> <p align="justify">“We delivered solid results in a competitive environment, with increased revenues and backlog offset by increased costs,” stated Nick Green, president and CEO of Avid Bioservices. “We are pleased to reach http://www.streetinsider.com/Press+Releases/Avid+Bioservices+Reports+Financial+Results+for+Second+Quarter+Ended+October+31%2C+2024/24088278.html Tue, 10 Dec 2024 16:05:00 -0500 A.33758567 CDMO CDMOP O.00639255 O.16915665